Agf Investments LLC Neurocrine Biosciences Inc Transaction History

Agf Investments LLC

$1.09 Billion
Q3 2022

A detailed history of Agf Investments LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Agf Investments LLC holds 16,003 shares of NBIX stock, worth $2.01 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

16,003

Previous 10,902 46.79%

Holding current value

$2.01 Million

Previous $1.06 Million 59.92%

% of portfolio

0.16%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $469,445 - $549,938	5,101 Added 46.79%	16,003 $1.7 Million
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $100,724 - $132,993	1,329 Added 13.88%	10,902 $1.06 Million
Q1 2022 May 10, 2022	BUY	$72.45 - $94.81 $693,563 - $907,616	9,573 New	9,573 $897,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $680,068 - $927,260	-7,766 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$86.91 - $108.33 $391,529 - $488,026	-4,505 Reduced 36.71%	7,766 $744,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $221,744 - $311,655	2,306 Added 23.14%	12,271 $1.18 Million
Q2 2020 Aug 11, 2020	BUY	$85.09 - $130.36 $148,737 - $227,869	1,748 Added 21.27%	9,965 $1.22 Million
Q1 2020 May 08, 2020	BUY	$75.11 - $113.76 $66,847 - $101,246	890 Added 12.15%	8,217 $711,000
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $236,443 - $322,984	2,724 Added 59.18%	7,327 $788,000
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $385,823 - $467,204	4,603 New	4,603 $415,000
Q4 2018 Feb 08, 2019	SELL	$68.32 - $124.36 $14,688 - $26,737	-215 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$98.88 - $125.85 $6,427 - $8,180	-65 Reduced 23.21%	215 $27,000
Q3 2018 Nov 07, 2018	SELL	$98.88 - $125.85 $8,305 - $10,571	-84 Reduced 23.08%	280 $24,000
Q2 2018 Aug 13, 2018	SELL	$75.3 - $105.99 $32,228 - $45,363	-428 Reduced 54.04%	364 $36,000
Q1 2018 May 04, 2018	BUY	$75.88 - $92.43 $23,219 - $28,283	306 Added 62.96%	792 $66,000
Q4 2017 Feb 07, 2018	BUY	$58.53 - $77.59 $28,445 - $37,708	486	486 $38,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.

Account

Agf Investments LLC Neurocrine Biosciences Inc Transaction History